GW Pharma (GWPH) Reports Q2 Revenue of $4.6M, Tops Consensus by~$2M

GW Pharma (NASDAQ: GWPH) reported Q2 EPS of $. Revenue for the quarter came in at $4.6 million versus the consensus estimate of $2.62 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• First Watch (FWRG) PT Lowered to $15 at DA Davidson, Buy Rating Maintained
• Carnival Corp. (CCL) Tops Q3 EPS by 8c